Cardinal Health the First Project Is for Case Study

Total Length: 1197 words ( 4 double-spaced pages)

Total Sources: 2

Page 1 of 4

Cardinal Health

The first project is for Micron Technology. The net present value analysis will be used to evaluate this project. The net present value (NPV) technique involves discounting future cash flows to present dollars, to take into account the firm's opportunity cost of capital. As a basic rule, projects that have a positive net present value will add value to the company above and beyond existing operations. All such projects with a positive NPV should be accepted, while projects with a negative NPV should be rejected.

There are a few different approaches to calculating the net present value, but they are all fundamentally the same, based on the principle of discounted cash flow analysis. The first flow is the initial cash outlay. Because this particular cash flow is made today, it is not discounted. This is because payments made today are already in present value format. Future cash flows, however, must be discounted by the discount rate, which in this case is 9%. The formula for NPV is as follows:

Source: Investopedia (2012)

The net present value for each cash flow can be calculated individually, or with the NPV function on Excel. The following example uses both methods:

Year

Flow

-2225000

350000

939000

720000

500000

900000

PV

-2225000

321101

790338

555972

354213

584938

NPV

381561

or

2606561

381561

d

0.09

The final NPV of this project is $381,561. This means that the project adds value to the company. Thus, it is recommended that Micron management accept this project.

Part II: In general, mergers benefit the companies involved when there are synergies between the companies that can translate to added value. The base assumption in a merger is that the price of a company on the stock market reflects its value.
Acquiring firms almost always pay a premium for the merger, so they need to see addition, synergistic value from the merger in order to justify it to their shareholders. Not knowing much about chips, it is not easy to tell if the merger would add value to the shareholders of all three corporations. It seems that the merger is to result in a combined entity that can compete against rivals that are larger and better financed. Building size to compete on cost with larger rivals often delivers value for the shareholders of the merged companies.

In order to assess the value of the deal to shareholders, two different things would need to be known. The first is whether there are any technological synergies between these companies. If combining the patents and technology of all the three companies will allow the new entity to produce chips that are either cheaper or superior to those of competitors, then the deal would deliver In addition, if the deal would give the combined entity superior market access -- for example access to larger customers -- then the deal would also hold value for the companies. It should also be noted that it is only the acquiring firm that pays a premium. The shareholders of Nanya and Micron will benefit from the initial transaction because a premium will be paid for their shares. The shareholders of Elpida will only benefit of the above-mentioned synergies arise. Elpida shareholders could also benefit if the combined entity has superior access to inputs, at better prices than before.

There are pitfalls, however, to such merger activity. If there are no synergies with the technology, the management or the organizational culture, the acquiring firm could fail to derive value from the.....

Need Help Writing Your Essay?